Abbot gets clearance for Alinity Molecular Diagnostics
/Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays
“NEW YORK (GenomeWeb) – Abbott announced today that it has received CE marking for its Alinity molecular diagnostics system and assays, which are now available in countries that recognize the designation.
The firm said that its molecular system will help clinicians who are struggling to keep up with demand for infectious disease testing.
The MDx platform offers a number of initial assays, including virology testing for human immunodeficiency virus type 1, hepatitis B virus, and hepatitis C virus; sexual health-related testing for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium, or a CT/NG/TV/MG panel; and high-risk human papillomavirus testing.“
